Pharma Stability: Insights, Guidelines, and Expertise
Biologics are large, complex molecules prone to degradation through mechanisms such as aggregation, deamidation, oxidation, and fragmentation. These changes can compromise efficacy, safety, and immunogenicity — especially under improper storage or handling conditions.
Click to read the full article.
Shelf-life extensions are considered when:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Stability testing is vital during tech transfers to ensure that the product maintains its quality, safety, and efficacy throughout its shelf life when produced at a new site or with updated equipment/processes.
Click to read the full article.
ICH Q1F was introduced to extend the scope of ICH Q1A(R2) by providing storage condition guidance tailored to different climatic zones:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.